The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosis. Endocrine
Subscribe to Our Newsletter
You are leaving this research use-only area
You are about to access content intended for a different region. Information, regulatory status, and product availability may vary by location.
